Amphastar Pharma (NASDAQ: AMPH) reported Q1 EPS of $0.42, $0.30 worse than the analyst estimate of $0.72. Revenue for the quarter came in at $171.2 million versus the consensus estimate of $176.32 million.

For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.